ReviewMolecules (Basel, Switzerland)2026
Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis: Mechanistic Considerations Across Relapsing and Progressive Disease.
Qiying Ye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.